Answer
It is licensed as an additional test for suspected breast lesions when recommended initial assessments are inconclusive. A negative result does not exclude cancer, and it is not indicated for staging.
Sources for this answer
- MYOVIEW 230 micrograms kit for radiopharmaceutical preparation — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.